Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McConkey

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Current Opinion in Rheumatology|June 1, 1991
Disease-modifying antirheumatic drugs: gold, penicillamine, antimalarials, and sulfasalazineB McConkey
British Medical Journal|September 6, 1980
Drugs and rheumatoid arthritisB McConkey
British Journal of Rheumatology|April 1, 1990
It is said that elevated erythrocyte sedimentation rate and the elevation of C-reactive protein (CRP) may be indicators of continuing joint destruction in rheumatoid arthritis. What then is the explanation for joint destruction in some patients in whom there is no such apparent elevation of either the sedimentation rate of CRP?B McConkey
British Medical Journal (Clinical Research Ed.)|November 14, 1981
Policeman's heelB McConkey
British Medical Journal (Clinical Research Ed.)|June 12, 1982
Rheumatoid cervical myelopathyB McConkey
Agents and Actions|September 1, 1976
New drugs for inflammation - a clinical viewpoint for their assessmentB McConkey
Lancet (London, England)|September 10, 1977
Alpha-1-antitrypsin and rheumatoid arthritisL Walsh, B McConkey
The Quarterly Journal of Medicine|January 1, 1986
The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritisP J Forster, B McConkey
The Journal of Rheumatology|December 1, 1984
Rheumatoid arthritis: the effects of treatment with dapsone on hemoglobinK A Grindulis, B McConkey
The Journal of Rheumatology|May 1, 1991
Rifampicin in rheumatoid arthritisB McConkey, R D Situnayake
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Current Opinion in Rheumatology|June 1, 1991
Disease-modifying antirheumatic drugs: gold, penicillamine, antimalarials, and sulfasalazineB McConkey
British Medical Journal|September 6, 1980
Drugs and rheumatoid arthritisB McConkey
British Journal of Rheumatology|April 1, 1990
It is said that elevated erythrocyte sedimentation rate and the elevation of C-reactive protein (CRP) may be indicators of continuing joint destruction in rheumatoid arthritis. What then is the explanation for joint destruction in some patients in whom there is no such apparent elevation of either the sedimentation rate of CRP?B McConkey
British Medical Journal (Clinical Research Ed.)|November 14, 1981
Policeman's heelB McConkey
British Medical Journal (Clinical Research Ed.)|June 12, 1982
Rheumatoid cervical myelopathyB McConkey
Agents and Actions|September 1, 1976
New drugs for inflammation - a clinical viewpoint for their assessmentB McConkey
Lancet (London, England)|September 10, 1977
Alpha-1-antitrypsin and rheumatoid arthritisL Walsh, B McConkey
The Quarterly Journal of Medicine|January 1, 1986
The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritisP J Forster, B McConkey
The Journal of Rheumatology|December 1, 1984
Rheumatoid arthritis: the effects of treatment with dapsone on hemoglobinK A Grindulis, B McConkey
The Journal of Rheumatology|May 1, 1991
Rifampicin in rheumatoid arthritisB McConkey, R D Situnayake
Pageof 7